FDA grants Ivermectin compassionate special permit to another hospital
MANILA, Philippines — Another hospital has been granted a compassionate special permit (CSP) to use Ivermectin in the treatment of COVID-19, Food and Drug Administration (FDA) Director-General Eric Domingo disclosed Friday.
Domingo did not disclose which hospital was given the second CSP for Ivermectin. He merely said it is a private hospital.
“Two hospitals na actually ‘yung nag-apply sa atin and have been given CSP,” Domingo said in an interview with ABS-CBN News Channel’s Headstart.
Domingo also confirmed the information to INQUIRER.net in a text message.
On April 8, FDA announced it has granted a hospital, the name of which was not disclosed due to privacy issues, a CSP for the use of Ivermectin to counter COVID-19.
The FDA gives CSP to allow limited use of investigational drugs or unregistered drugs.
KGA
For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.
